TENS for Phantom Limb Pain Prevention Following Major Amputation
NCT ID: NCT02496351
Last Updated: 2015-07-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
40 participants
INTERVENTIONAL
2015-05-31
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to assess if the early use of TENS in the immediately postoperative of major limb amputation due to peripheral vascular disease, should decrease the PLP incidence. TENS should interfere in the mechanism of PLP production to level of the pain fibers conduction.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Direct Nerve Stimulation for Treatment of Phantom Limb Pain
NCT02493842
Sensory Retraining for Phantom Limb Pain
NCT04103983
Surface Electrical Stimulation for Treatment of Phantom Limb Pain
NCT02488668
Effect of Transcutaneous Electrical Nerve Stimulation in Peripheral Artery Disease TENS-PAD Study / TENS-AOMI
NCT02678403
Electrical Stimulus Therapy for Chronic Phantom Limb Pain
NCT03030079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Postamputation pain is highly prevalent after vascular limb amputation. The physiopathological basis should be divided in supraspinal, spinal and peripheral mechanisms. Supraspinal mechanism involve somatosensory cortical reorganization; spinal reorganization in the dorsal horn, occurs after deafferentation from peripheral nerve injury and peripherical nerve injury begins with the nerve section in surgery. All this factors seems to end into a somatosensory cortex reorganization. In this sense, it seems that our ability to prevent PLP depend on the capability to modulate the plasticity of the Central Nervous System (CNS).
Transcutaneous electrical nerve stimulation it´s a safe, easy and inexpensive analgesic technique acting on the conduction pathways of pain. An adequated program is mandatory: balanced symmetrical biphasic pulse, pulse length greater than 250microsg, modulated high frequency and electrodes placed over the dermatomes corresponding to lumbar-sacral spine; will be used in the intervention patients
Hypothesis:
In patients with TENS use during the immediately postoperative of major limb amputation due to peripheral vascular disease, phantom limb pain will appear with less frequency than in control patients.
Study population:
Patients undergoing major limb amputation for peripheral vascular disease.
Study design:
A randomized, prospective, blinded (patient, physician, statistician),clinical trial placebo versus intervention group study has been design.
In the intervention arm, TENS should be applied during the 24 hours immediately after limb amputation. The placebo arm, also will carry TENS but without an active program.
All patients should receive the standard analgesic treatment for limb amputation during their hospitalization time.
Evaluation and objectives:
Before surgery all patients made two test for pain evaluation: The Analogical Visual Scale and the DN4 questionnaire for neuropathic pain.
At 3 days, 1 month and 3 months after surgery, all patients will be evaluated about their pain using the recommended test for neuropathic pain:The Analogical Visual Scale and the DN4 (neuropathic pain 4) questionnaire for neuropathic pain . Also, at month 1 and 3th, two more test should be done in order to evaluate quality of life: The SF-12 (short form-12) health survey questionnaire about health and the Medical Outcomes Study (MOS) for sleep test.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TENS INTERVENTION
In the immediately postoperative of limb amputation, TENS will be use in this patients during 24 hours. The intensity of the impulse will be determined in a test carried out 3 days before surgery. The other parameters will be continuous, biphasic, compensated and symmetric impulse, frequency of 80 Hz, time impulse between 250 and 290 microseconds, modulation time 5´´
TENS INTERVENTION
24 hours of TENS treatment in the immediately postoperative of limb amputation
TENS NO INTERVENTION
In the immediately postoperative of limb amputation, TENS will be use in this patients during 24 hours, but in this case TENS just will be on. No intensity impulse should be programmed.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
TENS INTERVENTION
24 hours of TENS treatment in the immediately postoperative of limb amputation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Critical limb ischemia (arteriopathic or diabetic aetiology)
* "MINI MENTAL TEST" (minimum 24 points)
Exclusion Criteria
* Don´t speak Spanish
* Not agreement with the study
* Dermatological lesion affecting the electrode place
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Barbara Bodega
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Barbara Bodega, Mrs
Role: PRINCIPAL_INVESTIGATOR
Hospital General Universitario de Castellon. Avenida Benicassim sn 12004. Castellon. Spain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
hospital General Universitario de Castellon
Castellon, Castellon de La Plana, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
161976BBM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.